What Factors Influence In-Hospital Mortality Following Aseptic Revision Total Hip Arthroplasty? : A Single-Center Analysis of 13,203 Patients.

IF 3.4 2区 医学 Q1 ORTHOPEDICS Journal of Arthroplasty Pub Date : 2024-09-02 DOI:10.1016/j.arth.2024.08.052
Taner Karlidag, Maximilian Budin, T David Luo, M Fatih Dasci, Thorsten Gehrke, Mustafa Citak
{"title":"What Factors Influence In-Hospital Mortality Following Aseptic Revision Total Hip Arthroplasty? : A Single-Center Analysis of 13,203 Patients.","authors":"Taner Karlidag, Maximilian Budin, T David Luo, M Fatih Dasci, Thorsten Gehrke, Mustafa Citak","doi":"10.1016/j.arth.2024.08.052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Revision total hip arthroplasty (rTHA) is associated with an extended surgical period, an increased hospitalization period, expanded blood loss, and high mortality rates. The purpose of the current study was to assess the risk factors that contribute to in-hospital mortality following aseptic rTHA.</p><p><strong>Methods: </strong>We performed a retrospective examination of the medical records of all patients who underwent elective rTHA surgery at our tertiary referral arthroplasty center between March 1996 and March 2019. The study involved a group of 13,203 patients, including 70 who expired during hospitalization and 13,133 in the control group. Baseline characteristics, medical history, comorbidities, and surgery-related parameters of the patients were recorded. Logistic regression analyses were performed to examine the association between independent variables and in-hospital mortalities, which were presented as odds ratios (OR) and confidence intervals (CI).</p><p><strong>Results: </strong>Patient factors associated with in-hospital mortality included hepatitis C (OR 75.5, 95% CI 3.5 to 1,625.2), chronic obstructive pulmonary disease (OR 30.7, 95% CI 6.5 to 145.7), rheumatoid arthritis (OR 28.9, 95% CI 3.8 to 218.5), history of myocardial infarction (OR 24.9, 95% CI 4.4 to 140.8), history of cerebrovascular disease (OR 23.1, 95% CI 3.8 to 142), congestive heart failure (OR 18.9, 95% CI 3.8 to 94.2), and diabetes mellitus (OR 10.2, 95% CI 2.4 to 42.6). Surgical factors included the history of multiple prior revisions (OR 1.75, 95% CI 1.1 to 2.7), postoperative blood transfusion (OR 2.8, 95% CI 1.1 to 7.3), and decreased preoperative hemoglobin (OR 2.3, 95% CI 1.7 to 3.1).</p><p><strong>Conclusion: </strong>Several patient-related and intraoperative factors significantly increased the risk of in-hospital mortality following aseptic revision THA. Vigilance and close perioperative monitoring are essential for patients undergoing this complex surgery.</p>","PeriodicalId":51077,"journal":{"name":"Journal of Arthroplasty","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroplasty","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arth.2024.08.052","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Revision total hip arthroplasty (rTHA) is associated with an extended surgical period, an increased hospitalization period, expanded blood loss, and high mortality rates. The purpose of the current study was to assess the risk factors that contribute to in-hospital mortality following aseptic rTHA.

Methods: We performed a retrospective examination of the medical records of all patients who underwent elective rTHA surgery at our tertiary referral arthroplasty center between March 1996 and March 2019. The study involved a group of 13,203 patients, including 70 who expired during hospitalization and 13,133 in the control group. Baseline characteristics, medical history, comorbidities, and surgery-related parameters of the patients were recorded. Logistic regression analyses were performed to examine the association between independent variables and in-hospital mortalities, which were presented as odds ratios (OR) and confidence intervals (CI).

Results: Patient factors associated with in-hospital mortality included hepatitis C (OR 75.5, 95% CI 3.5 to 1,625.2), chronic obstructive pulmonary disease (OR 30.7, 95% CI 6.5 to 145.7), rheumatoid arthritis (OR 28.9, 95% CI 3.8 to 218.5), history of myocardial infarction (OR 24.9, 95% CI 4.4 to 140.8), history of cerebrovascular disease (OR 23.1, 95% CI 3.8 to 142), congestive heart failure (OR 18.9, 95% CI 3.8 to 94.2), and diabetes mellitus (OR 10.2, 95% CI 2.4 to 42.6). Surgical factors included the history of multiple prior revisions (OR 1.75, 95% CI 1.1 to 2.7), postoperative blood transfusion (OR 2.8, 95% CI 1.1 to 7.3), and decreased preoperative hemoglobin (OR 2.3, 95% CI 1.7 to 3.1).

Conclusion: Several patient-related and intraoperative factors significantly increased the risk of in-hospital mortality following aseptic revision THA. Vigilance and close perioperative monitoring are essential for patients undergoing this complex surgery.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
影响无菌翻修全髋关节置换术后院内死亡率的因素有哪些? 13203 例患者的单中心分析。
背景:翻修全髋关节置换术(rTHA)与手术时间延长、住院时间延长、失血量增加和高死亡率相关。本研究旨在评估导致无菌 rTHA 术后院内死亡率的风险因素:我们对 1996 年 3 月至 2019 年 3 月期间在我们的三级关节成形术转诊中心接受择期 rTHA 手术的所有患者的病历进行了回顾性检查。研究涉及 13203 名患者,包括 70 名在住院期间去世的患者和 13133 名对照组患者。研究记录了患者的基线特征、病史、合并症和手术相关参数。通过逻辑回归分析研究自变量与院内死亡率之间的关系,结果以几率比(OR)和置信区间(CI)表示:结果:与院内死亡率相关的患者因素包括丙型肝炎(OR 75.5,95% CI 3.5 至 1625.2)、慢性阻塞性肺病(OR 30.7,95% CI 6.5 至 145.7)、类风湿性关节炎(OR 28.9,95% CI 3.8 至 218.5)、心肌梗死病史(OR 30.7,95% CI 6.5 至 145.7)、心肌梗死病史(OR 28.9,95% CI 3.8 至 218.5)。5)、心肌梗死病史(OR 24.9,95% CI 4.4 至 140.8)、脑血管疾病病史(OR 23.1,95% CI 3.8 至 142)、充血性心力衰竭(OR 18.9,95% CI 3.8 至 94.2)和糖尿病(OR 10.2,95% CI 2.4 至 42.6)。手术因素包括既往多次翻修史(OR 1.75,95% CI 1.1 至 2.7)、术后输血(OR 2.8,95% CI 1.1 至 7.3)和术前血红蛋白降低(OR 2.3,95% CI 1.7 至 3.1):结论:患者相关因素和术中因素显著增加了无菌翻修THA术后的院内死亡风险。对于接受这种复杂手术的患者来说,保持警惕和密切的围手术期监测至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Arthroplasty
Journal of Arthroplasty 医学-整形外科
CiteScore
7.00
自引率
20.00%
发文量
734
审稿时长
48 days
期刊介绍: The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.
期刊最新文献
Editorial Board Masthead Table of Contents Conflict of Interest Statement Letter to the Editor on “Impact of Reporting Bias, Conflict of Interest, and Funding Sources on Quality of Orthopaedic Research”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1